prostate-report.org

Better survival associated with higher doses of EBRT

It has been getting increasingly clear that elevated doses of radiation to the prostate result in better prostate cancer-specific survival for men treated with first-line radiotherapy for localized prostate cancer.

A recent study suggests that  for patients with localized prostate cancer who elect to receive external beam radiation therapy (EBRT), a dose of 78 Gy decreases risk for biochemical and clinical failure and risk for  prostate cancer-specific mortality in patients with a pretreatment PSA >10 ng/ml or high-risk disease.